![](/images/ico/ico_close.png)
![](/images/ico/ico5.png)
Publisher: Bentham Science Publishers
E-ISSN: 2212-3873|12|4|368-376
ISSN: 1871-5303
Source: Endocrine, Metabolic & Immune Disorders-Drug Targets (Formerly Current Drug Targets - Immune, Endocrine & Metabolic Disorders), Vol.12, Iss.4, 2012-12, pp. : 368-376
Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.
Abstract
Related content
![](/images/ico/ico_close.png)
![](/images/ico/ico5.png)
Ascorbic Acid as Modulator of Immune Function in Sepsis
Letters in Drug Design & Discovery, Vol. 2, Iss. 3, 2005-05 ,pp. :
![](/images/ico/ico_close.png)
![](/images/ico/ico5.png)
![](/images/ico/ico_close.png)
![](/images/ico/ico5.png)
![](/images/ico/ico_close.png)
![](/images/ico/ico5.png)
Host Innate Immune Responses Induced by Baculovirus in Mammals
Current Gene Therapy, Vol. 10, Iss. 3, 2010-06 ,pp. :
![](/images/ico/ico_close.png)
![](/images/ico/ico5.png)
Role of DAP12 in Innate and Adaptive Immune Responses
Current Pharmaceutical Design, Vol. 9, Iss. 1, 2003-01 ,pp. :